Transplantation - Updates

Transplantation - Highlighted Tweets

Regulatory T Cell Biomarkers Identify Patients at Risk of Developing Acute Cellular Rejection in the First Year Following Heart Transplantation
Acute cellular rejection (ACR), an alloimmune response involving CD4+ and CD8+ T cells, occurs in up to 20% of patients within the first year following heart transplantation. The balance between a conventional versus regulatory CD4+ T cell alloimmune response is believed to contribute to developing ACR. Therefore, tracking these cells may elucidate whether changes in these cell populations could signal ACR risk.
Maximize Donor Cornea Use in a Hepatitis B Endemic Area via Serology Matching
This study aims to investigate the rationality of the allocation guidelines in a hepatitis B endemic area that uses corneas from hepatitis B donors.

Transplantation Direct - Highlighted Tweets

Low C-reactive Protein and Urea Distinguish Primary Nonfunction From Early Allograft Dysfunction Within 48 Hours of Liver Transplantation
Primary nonfunction (PNF) is a life-threatening complication of liver transplantation (LT), but in the early postoperative period, it can be difficult to differentiate from early allograft dysfunction (EAD). The aim of this study was to determine if serum biomarkers can distinguish PNF from EAD in the initial 48 h following LT.
Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
Lung transplant recipients (LTRs) have an increased risk of COVID-19–related morbidity and mortality. Tixagevimab-cilgavimab (tix-cil) is a long-acting monoclonal antibody combination granted Emergency Use Authorization approval by the US Food and Drug Administration for COVID-19 pre-exposure prophylaxis (PrEP) in immunocompromised patients. We sought to determine whether tix-cil 300–300 mg reduced the incidence and disease severity of severe acute respiratory syndrome coronavirus 2 infection in LTRs during the Omicron wave.

ISUTx 2023 - Registration is Now Open!

Join us for two days of engaging panel discussions, presentations, and networking with internationally-renowned faculty and researchers.

The International Society of Uterus Transplantation (ISUTx) is dedicated to scientific innovation and advances in medical care in the field of uterus transplantation.

This year, the ISUTx will commemorate and celebrate the future of the field with this year’s theme — “Uterus Transplantation: The Next Generation.”

We look forward to seeing attendees at the 4th International Congress, which will be held in-person in Birmingham, Alabama at “The Forum” at the Sheraton Birmingham Hotel, on Monday, September 11 – Tuesday, September 12, 2023.

SPLIT 2023 - Early-bird Registration Deadline

Register Today and Save - Early-bird Registration Ends Tomorrow, July 15!

We appreciate your ongoing attendance at our Society’s meeting, which provides excellent educational content and opportunities for fellowship, community and networking. This year’s meeting will mark a number of changes including that our meeting has moved to take place on Monday and Tuesday instead of our usual Thursday/Friday. Additionally, as an official Section of The Transplantation Society we have engaged them as a partner in organizing and supporting the continued growth of our meeting.

We plan on welcoming leading experts and opinion leaders from all over the world to present their latest data and address important needs in clinical pediatric liver transplant and hosting sessions devoted to emerging research in the field.

IPITA-IXA-CTRMS Joint Congress

Early-bird Registration Deadline: July 24
Take advantage of the reduced fees!

The International Pancreas and Islet Transplant Association (IPITA), the International Xenotransplantation Association (IXA), and the Cell Transplant and Regenerative Medicine Society (CTRMS) reaffirm their strong partnership as leaders in transplantation and promise to provide an outstanding and innovative program.

Leading experts and opinion leaders from all over the world will present the latest data and address important needs in clinical and experimental transplant therapy. Specific sessions will be devoted to hot research in whole-organ pancreas transplantation, islet transplantation, stem cell therapy, xenotransplantation and transplant biology.

We are expecting close to 600 delegates from all over the world.

We look forward to welcoming YOU to San Diego!

In the News 



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6